@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C04AE01> a ns1:ATCConcept ;
    skos:notation "C04AE01" ;
    skos:prefLabel "Hydrogenované námelové alkaloidy"@cs,
        "Ergoloid mesylates"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0007657> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000273>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> ;
    ns1:description "A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000099>,
        <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000130>,
        <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000209> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/SECATOXIN-FORTE> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000493>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028009> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008351>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008376> ;
    ns1:mayPrevent <http://linked.opendata.cz/resource/ndfrt/disease/N0000001484> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000000798>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001484> ;
    ns1:title "Námelové alkaloidy hydrogenované"@cs,
        "Ergoloid mesylates"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0000493> a ns1:PharmacologicalAction ;
    ns1:description "Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.     "@en ;
    ns1:title "Receptory adrenergní alfa - blokátory"@cs,
        "Adrenergic alpha-antagonists"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used to cause dilation of the blood vessels.     "@en ;
    ns1:title "Vasodilatancia"@cs,
        "Vasodilator agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028009> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.     "@en ;
    ns1:title "Nootropní látky"@cs,
        "Nootropic agents"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000273> a ns1:DiseaseOrFinding ;
    ns1:description "UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE.     "@en ;
    ns1:title "Hrozící potrat"@cs,
        "Abortion, threatened"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000798> a ns1:DiseaseOrFinding ;
    ns1:description "A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)     "@en ;
    ns1:title "Cluster headache"@cs,
        "Cluster headache"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001484> a ns1:DiseaseOrFinding ;
    ns1:description "Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).     "@en ;
    ns1:title "Poporodní hemoragie"@cs,
        "Postpartum hemorrhage"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000010195> a ns1:DiseaseOrFinding ;
    ns1:description "The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.     "@en ;
    ns1:title "Těhotenství"@cs,
        "Pregnancy"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000099> a ns1:MechanismOfAction ;
    ns1:title "Adrenergic alpha-Antagonists"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000130> a ns1:MechanismOfAction ;
    ns1:title "Serotonin Antagonists"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000209> a ns1:MechanismOfAction ;
    ns1:title "Adrenergic alpha-Agonists"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008351> a ns1:PhysiologicEffect ;
    ns1:title "Cerebral Arterial Vasoconstriction"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000008376> a ns1:PhysiologicEffect ;
    ns1:title "Cutaneous Arterial Vasoconstriction"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/SECATOXIN-FORTE> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C04AE01> ;
    ns1:title "SECATOXIN FORTE"@cs .


